BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35076461)

  • 1. Study Design for an Evaluation of Newborn Screening for SCID in the UK.
    Elliman D
    Int J Neonatal Screen; 2022 Jan; 8(1):. PubMed ID: 35076461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of neonatal UK dried blood spots using a duplex TREC screening assay.
    Adams SP; Rashid S; Premachandra T; Harvey K; Ifederu A; Wilson MC; Gaspar HB
    J Clin Immunol; 2014 Apr; 34(3):323-30. PubMed ID: 24668299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK.
    Bessey A; Chilcott J; Leaviss J; de la Cruz C; Wong R
    Int J Neonatal Screen; 2019 Sep; 5(3):28. PubMed ID: 33072987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for SCID in New York State: experience from the first two years.
    Vogel BH; Bonagura V; Weinberg GA; Ballow M; Isabelle J; DiAntonio L; Parker A; Young A; Cunningham-Rundles C; Fong CT; Celestin J; Lehman H; Rubinstein A; Siegel S; Weiner L; Saavedra-Matiz C; Kay DM; Caggana M
    J Clin Immunol; 2014 Apr; 34(3):289-303. PubMed ID: 24578017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
    Richards S; Pitt J; Choo S
    J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population.
    Gaviglio A; Lasarev M; Sheller R; Singh S; Baker M
    Int J Neonatal Screen; 2023 Dec; 9(4):. PubMed ID: 38132827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results.
    Thomas C; Durand-Zaleski I; Frenkiel J; Mirallié S; Léger A; Cheillan D; Picard C; Mahlaoui N; Riche VP; Roussey M; Sébille V; Rabetrano H; Dert C; Fischer A; Audrain M
    Clin Immunol; 2019 May; 202():33-39. PubMed ID: 30946917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
    Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
    JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain).
    Argudo-Ramírez A; Martín-Nalda A; Marín-Soria JL; López-Galera RM; Pajares-García S; González de Aledo-Castillo JM; Martínez-Gallo M; García-Prat M; Colobran R; Riviere JG; Quintero Y; Collado T; García-Villoria J; Ribes A; Soler-Palacín P
    Front Immunol; 2019; 10():2406. PubMed ID: 31695692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency-Clinical Achievements and Insights.
    Rechavi E; Lev A; Simon AJ; Stauber T; Daas S; Saraf-Levy T; Broides A; Nahum A; Marcus N; Hanna S; Stepensky P; Toker O; Dalal I; Etzioni A; Almashanu S; Somech R
    Front Immunol; 2017; 8():1448. PubMed ID: 29167666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of population-based newborn screening for severe combined immunodeficiency.
    Chan K; Puck JM
    J Allergy Clin Immunol; 2005 Feb; 115(2):391-8. PubMed ID: 15696101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.
    de Felipe B; Olbrich P; Lucenas JM; Delgado-Pecellin C; Pavon-Delgado A; Marquez J; Salamanca C; Soler-Palacin P; Gonzalez-Granado LI; Antolin LF; Borte S; Neth O
    Pediatr Allergy Immunol; 2016 Feb; 27(1):70-7. PubMed ID: 26498110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases.
    Jilkina O; Thompson JR; Kwan L; Van Caeseele P; Rockman-Greenberg C; Schroeder ML
    Mol Genet Metab Rep; 2014; 1():324-333. PubMed ID: 27896105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program.
    Blom M; Bredius RGM; Weijman G; Dekkers EHBM; Kemper EA; van den Akker-van Marle ME; van der Ploeg CPB; van der Burg M; Schielen PCJI
    Int J Neonatal Screen; 2018 Dec; 4(4):40. PubMed ID: 33072960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopenia].
    Olbrich P; de Felipe B; Delgado-Pecellin C; Rodero R; Rojas P; Aguayo J; Marquez J; Casanovas J; Sánchez B; Lucena JM; Ybot-Gonzalez P; Borte S; Neth O
    An Pediatr (Barc); 2014 Nov; 81(5):310-7. PubMed ID: 25278007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
    Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
    Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Severe Combined Immunodeficiency: Do Preterm Infants Require Special Consideration?
    Atkins AE; Cogley MF; Baker MW
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a routine newborn screening protocol for severe combined immunodeficiency.
    Baker MW; Grossman WJ; Laessig RH; Hoffman GL; Brokopp CD; Kurtycz DF; Cogley MF; Litsheim TJ; Katcher ML; Routes JM
    J Allergy Clin Immunol; 2009 Sep; 124(3):522-7. PubMed ID: 19482345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal screening of severe combined immunodeficiencies].
    Thomas C; Mirallié S; Pierres C; Dert C; Clément MC; Mahlaoui N; Durand-Zaleski I; Fischer A; Audrain M;
    Arch Pediatr; 2015 Jun; 22(6):646-52. PubMed ID: 25896629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.